Based on the data suggesting potential synergism, and the rationale to target multiple downstream pathways, we conducted a Ciprofloxacin and Celecoxib combination treatment in two well‐characterized genetic ALS zebrafish models carrying the SOD1 or TAR DNA binding protein 43 (TARDBP) mutations. Here, TARDBP is linked to amyotrophic lateral sclerosis.